AMTURNIDE Trademark

Trademark Overview

On Thursday, October 28, 2010, a trademark application was filed for AMTURNIDE with the United States Patent and Trademark Office. The USPTO has given the AMTURNIDE trademark a serial number of 85163302. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 3, 2021. This trademark is owned by Novartis AG. The AMTURNIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the cardiovascular system
amturnide

General Information

Serial Number85163302
Word MarkAMTURNIDE
Filing DateThursday, October 28, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 3, 2021
Registration Number3972043
Registration DateTuesday, May 31, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of diseases and disorders of the cardiovascular system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 3, 2021
Primary Code005
First Use Anywhere DateMonday, January 31, 2011
First Use In Commerce DateMonday, January 31, 2011

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, December 3, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, May 31, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, April 17, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, April 17, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, April 17, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 20, 2017TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 31, 2011REGISTERED-PRINCIPAL REGISTER
Saturday, April 23, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, April 22, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, April 21, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 11, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 6, 2011USE AMENDMENT FILED
Monday, April 11, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 6, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, March 22, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 22, 2010ASSIGNED TO LIE
Tuesday, November 30, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 30, 2010ASSIGNED TO EXAMINER
Tuesday, November 23, 2010ASSIGNED TO PETITION STAFF
Monday, November 22, 2010TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Tuesday, November 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 1, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

amturnide disorders cardiovascular system diseases prevention preparations treatment pharmaceutical